PaCO~2~reflects the adequacy of alveolar ventilation in the intensive care unit patient. Arterial blood-gas sampling is considered the \'gold standard\'. There is, however, a significant morbidity associated with arterial line placement.

We compared the efficacy of transcutaneous monitoring of CO~2~(tcCO~2~) with traditional PaCO~2~from arterial blood-gas samples.

Method
======

We studied consecutive ICU admissions during an 8-day period. We included all new patients aged 18 and over who were expected to survive for 24 hours. A TOSCA transcutaneous monitor (tcCO~2~) was attached to the earlobe. The probe was moved every 4 hours and 4-hourly routine arterial blood-gas samples were taken and PaCO~2~values recorded.

Results
=======

We studied eight patients (four males and four females). The mean age was 56 years. The mean admission APACHEII and SAPS scores were 19.5 and 31.3, respectively. The mean hospital stay was 31 days. ICU survival was 75%. Two patients were ventilated using a high-frequency oscillator. A total of 64 comparisons were made.

We detected a significant difference between blood-gas PaCO~2~and TOSCA tcCO~2~of 0.43 kPa (paired *t*test *P*= 0.0012). Figure [1](#F1){ref-type="fig"} shows the bias and limits of agreements. A regression line was fitted and the slope and intercept were highly significant. It is possible to predict PaCO~2~from tcCO~2~using the following regression equation: PaCO~2~= 2.7 + 0.5 × tcCO~2~.

![Bland Altman plot of TOSCA data.](cc2522-1){#F1}

Conclusion
==========

Although there is a difference between PaCO~2~and tcCO~2~, it is possible to accurately predict the PaCO~2~level using tcCO~2~with moderate precision. tcCO~2~may be an adequate alternative to arterial blood gas sampling.
